LexaGene to Host Corporate Update on November 3
26. Oktober 2021 10:55 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing
25. Oktober 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an...
LexaGene’s Largest Study Validates Accuracy of its Veterinary Test Panel
07. Oktober 2021 07:45 ET
|
LexaGene Holdings Inc
Technology Accurately Identifies Pathogens and Predicts Antimicrobial Resistance In less than 30 years, drug resistant bacteria are predicted to kill 3 times more people on an annual basis than...
LexaGene Expands Brand Awareness at Key Investor Conferences
01. Oktober 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
LexaGene Reports on Recent Veterinary Trade Shows
30. September 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
LexaGene Adopts Corporate Governance Charters and Policies
17. September 2021 16:00 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a...
LexaGene Enters into Cooperative Research and Development Agreement with the United States Army’s Combat Capabilities Development Command
16. September 2021 07:45 ET
|
LexaGene Holdings Inc
BEVERLY, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
LexaGene’s MiQLab™ Accurately Detects Multiple Strains of Pathogenic Bacteria in Polymicrobial Samples Compared to Conventional Culture
07. September 2021 07:45 ET
|
LexaGene Holdings Inc
MiQLab detected both bacterial strains in polymicrobial samples in ~2 hoursCulture and Sensitivity Testing (C&ST) failed to detect the minor pathogen population in individual mixed samples, with...
Lexagene Files Preliminary Short Form Base Shelf Prospectus
03. September 2021 15:15 ET
|
LexaGene Holdings Inc
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES BEVERLY, Mass.,...
LexaGene’s MiQLab™ System Featured at Three Key Veterinary Tradeshows
03. September 2021 07:45 ET
|
LexaGene Holdings Inc
September 7-9, WVC 93rd Annual Conference, Las Vegas, NVSeptember 12-14, International Veterinary Emergency and Critical Care, Nashville, TNSeptember 23-26, Southwest Veterinary Symposium, San...